AVROBIO regains Nasdaq minimum bid price compliance after 10 consecutive days above $1.00

Tectonic Therapeutic, Inc.

Received Nasdaq notice on Feb 23, 2023 confirming compliance with Minimum Bid Price Requirement.
Closing bid price was at or above $1.00 for 10 consecutive business days from Feb 8 to Feb 22, 2023.
Nasdaq staff advised the matter is now closed; no further action required.
Previously disclosed non-compliance on Oct 4, 2022; now resolved.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.